Analyst Research: Gilead Sciences Inc (GILD.O)


GILD.O on Nasdaq

50.60USD
19 Jun 2013
Price Change (% chg)

$-1.34 (-2.58%)
Prev Close
$51.94
Open
$51.82
Day's High
$52.05
Day's Low
$50.57
Volume
6,408,557
Avg. Vol
12,219,417
52-wk High
$58.06
52-wk Low
$24.80

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - GILEAD SCIENCES, INC. (GILD-O) 19 Jun 2013 Thomson Reuters Stock Report 12 25.00
Gilead Sciences, Inc. 18 Jun 2013 Datamonitor 70 175.00
Gilead Sciences 15 Jun 2013 S&P Capital IQ – STARS Reports 10 115.00
GILEAD SCIENCES INC (GILD) 12-months forecast 14 Jun 2013 Pechala's Reports 1 15.00
Gilead Sciences Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 14 Jun 2013 Reuters Investment Profile 12 20.00
Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of GILEAD SCIENCES INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 13 Jun 2013 Jefferson Research 11 20.00
 

People

Name Age Since Current Position

John Martin

 61 2008 Chairman of the Board, Chief Executive Officer

John Milligan

 52 2008 President, Chief Operating Officer

Robin Washington

 50 2008 Chief Financial Officer, Senior Vice President

Norbert Bischofberger

 57 2007 Executive Vice President - Research and Development, Chief Scientific Officer

Gregg Alton

 47 2009 Executive Vice President - Corporate and Medical Affairs
» More People

Gilead Sciences Inc News

» More GILD.O News
Search Stocks